Testing a Provider-Level Feedback Intervention to Optimize Postoperative Prescribing

NCT04776928 | Completed Results

• 2 other identifiers: HUM001863525R01DA042859-04
• Study Type: interventional
• Target: 217
• Locations: 1 country
• Sites: 1

Brief Summary

The objective of this project is to leverage the Michigan Surgical Quality Collaborative's (MSQC) existing network and surgeon performance feedback platform to improve opioid prescribing practices for surgeons within the network found to be prescribing in a manner discordant with published guidelines and to inform best practices for future surgical quality improvement initiatives. The study is being completed to learn more about the effectiveness, feasibility, and acceptability and that the goal is both to evaluate how effective this intervention and mechanism are for changing surgeon opioid prescribing behavior and to inform best practices for future quality initiatives. The study hypothesizes that provider-level feedback will allow clinicians to tailor postoperative prescribing more closely to patient consumption, and reduce excess postoperative prescribing. The cohort of surgeons which have been identified as outliers by the Michigan Surgical Quality Collaborative (MSQC) will be be invited to participate in this trial. The study team will send surgeons belonging to sites that signed the Exhibit B-1 form the provider-level push notifications (98 participants). In this study de-identified prescribing data will also be analyzed for sites that do not sign the Exhibit B-1 form (105 participants). The study team will approach 98 surgeons receiving the provider-level push notifications in one wave.

Conditions

Opioid Prescribing

Keywords

Surgery

Outcome Measures

Primary Outcomes (1)

• Change in Opioid Prescribed Following the Intervention

  Oral morphine equivalents prescribed adjusted for surgery type as reported through MSQC data.

  up to 5 months from enrollment

Study Arms (2)

Provider-level push report notifications

EXPERIMENTAL

Push reports will be sent via using a secure email client. The email will be sent to the email address provided to the study team by the surgeon or site.

Behavioral: Push reports

No intervention

NO INTERVENTION

Sites who did not sign Exhibit B-1.

Interventions

Push reports BEHAVIORAL

Surgeons in the experimental arm will receive provider-level push report notifications through an email displaying their personal prescribing performance compared to Michigan Opioid Prescribing Engagement Network (OPEN) prescribing guidelines and their de-identified peers. The push report will also include a link to the secure MSQC data platform that displays more information about the case so the surgeon can further investigate prescribing information. The email will also contain contact information for the study team so as to help any surgeons troubleshoot, learn more, request to stop receiving reports, etc.

Provider-level push report notifications

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Surgeons already participating in and sharing data with the Michigan Surgical Quality Collaborative (MSQC) who perform procedures of interest
• Surgeons within MSQC who have median prescribing \> 1 pill equivalents over the published recommendation
• Surgeons within MSQC who perform surgeries at a hospital that have agreed to participate in this research

You may not qualify if:

• Surgeons not identified in the MSQC data as having a valid National Provider Identifier (NPI)

Sponsors & Collaborators

• University of Michigan: lead
• National Institute on Drug Abuse (NIDA): collaborator

Study Sites (1)

University of Michigan

Ann Arbor, Michigan, 48109, United States

Location

Results Point of Contact

• Title: Jennifer Waljee
• Organization: University of Michigan

filip@med.umich.edu

(734) 936-8925

Study Officials

• Jennifer F Waljee, MD

  University of Michigan

  PRINCIPAL INVESTIGATOR

Publication Agreements

• PI is Sponsor Employee: Yes

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NON RANDOMIZED
• Masking: SINGLE
• Who Masked: OUTCOMES ASSESSOR
• Purpose: HEALTH SERVICES RESEARCH
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Associate Professor of Surgery and Associate Professor of Orthopaedic Surgery

Study Record Dates

• First Submitted: February 25, 2021
• First Posted: March 2, 2021
• Study Start: March 17, 2022
• Primary Completion: August 17, 2022
• Study Completion: August 17, 2022
• Last Updated: November 21, 2023
• Results First Posted: November 21, 2023

Record last verified: 2023-11

Data Sharing

• IPD Sharing: Will not share

Locations

US (1)